Peritoneal macrophage priming in cirrhosis is related to ERK phosphorylation and IL-6 secretion

European Journal of Clinical Investigation

Volumn 41, Issue 1, 2011, Pages 8-15

  Ruiz Alcaraz, Antonio J ^a   Martínez Esparza, María ^a   Caño, Rocío ^b   Hernández Caselles, Trinidad ^a   Recarti, Chiara ^a   Llanos, Lucía ^b   Zapater, Pedro ^b,c   Tapia, Ana ^a   Martín Orozco, Elena ^a   Pérez Mateo, Miguel ^b   Such, José ^b,c   García Peñarrubia, Pilar ^a   Francés, Rubén ^b,c  

^a UNIVERSITY OF MURCIA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Ascitic fluid; Cirrhosis; Cytokines; Macrophages; MAP kinases

Indexed keywords

CD86 ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BACTERIAL TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIVER CIRRHOSIS; MALE; MONOCYTE; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION;

ADULT; AGED; ASCITIC FLUID; BACTERIAL TRANSLOCATION; CYTOKINES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; INTERLEUKIN-6; LIVER CIRRHOSIS; MACROPHAGES, PERITONEAL; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; PHOSPHORYLATION; PROSPECTIVE STUDIES;

EID: 78650055511     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02368.x     Document Type: Article

References (36)

1. Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis 1998;27:669-74.
2. Berg RD. Bacterial translocation from the gastrointestinal tract. J Med 1992;23:217-44.
3. Runyon BA. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology 1988;8:632-5.
4. Such J, Guarner C, Enriquez J, Rodriguez JL, Seres I, Vilardell F. Low C3 in cirrhotic ascites predisposes to spontaneous bacterial peritonitis. J Hepatol 1988;6:80-4.
5. Turchyn LR, Baginski TJ, Renkiewicz RR, Lesch CA, Mobley JL. Phenotypic and functional analysis of murine resident and induced peritoneal macrophages. Comp. Med. 2007;57:574-80.
6. Heller J, Sogni P, Barriére E, Tazi KA, Chauvelot-Moachon L, Guimont MC et al. Effects of lipopolysaccharide on TNF-alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis. J Hepatol 2000;33:376-81.
7. Riordan SM, Williams R. The intestinal flora and bacterial infections in cirrhosis. J Hepatol 2006;45:744-57.
8. Frances R, Zapater P, Gonzalez-Navajas JM, Muñoz C, Caño R, Moreu R et al. Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis. Hepatology 2008;47:978-85.
9. Frances R, Muñoz C, Zapater P, Uceda F, Gascón I, Pascual S et al. Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites. Gut 2004;53:860-4.
10. Such J, Hillebrand DJ, Guarner C, Berk L, Zapater P, Westengard J et al. Nitric oxide in ascitic fluid is an independent predictor of the development of renal impairment in patients with cirrhosis and spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol 2004;16:571-7.
11. Garcia-TSAO G, Angulo P, Garcia JC, Groszmann RJ, Cadelina GW. The diagnostic and predictive value of ascites nitric oxide levels in patients with spontaneous bacterial peritonitis. Hepatology 1998;28:17-21.
12. Such J, Hillebrand DJ, Guarner C, Berk L, Zapater P, Westengard J et al. Tumor necrosis factor alpha, interleukin-6 and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection. Dig Dis Sci 2001;46:2360-6.
13. Byl B, Roucloux I, Crusiaux A, Dupont E, Deviere J. Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients. Gastroenterology 1993;104:1492-7.
14. Albillos A, Cuervas Mons V, Millan I, Cantón T, Montes J, Barrios C et al. Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis. Gastroenterology 1990;98:134-40.
15. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995;273:117-23.
16. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med. 1996;334:693-9.
17. Runyon BA. Paracentesis of ascitic fluid: a safe procedure. Arch Intern Med 1986;146:2259-61.
18. Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology 1988;95:1351-5.
19. Albillos A, Hera Ad AL, Reyes E, Monserrat J, Muñoz L, Nieto M et al. Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis: amelioration with norfloxacin. J. Hepatol. 2004;40:624-31.
20. Zapater P, Cano R, Llanos L, Ruiz-Alcaraz AJ, Pascual S, Barquero C et al. Norfloxacin modulates the inflammatory response and directly affects neutrophils in patients with decompensated cirrhosis. Gastroenterology 2009;137:1669-79.
21. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
22. Such J, Frances R, Munoz C, Zapater P, Casellas JA, Cifuentes A et al. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites. Hepatology 2002;36:135-41.
23. Frances R, Benlloch S, Zapater P, González JM, Lozano B, Muñoz C et al. A sequential study of serum bacterial DNA in patients with advanced cirrhosis and ascites. Hepatology 2004;39:484-91.
24. Zapater P, Frances R, Gonzalez-Navajas JM, De La Hoz MA, Moreu R, Pascual S et al. Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis. Hepatology 2008;48:1924-31.
25. Jones SA. Directing transition from innate to acquired immunity: defining a role for IL-6. J. Immunol. 2005;175:3463-8.
26. Kishimoto T, Akira S, Narazaki M, Taga T. Interleukin-6 family of cytokines and gp130. Blood 1995;86:1243-54.
27. Barton BE, Jackson JV. Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model. Infect Immun 1993;61:1496-9.
28. Diao H, Kohanawa M. Endogenous interleukin-6 plays a crucial protective role in streptococcal toxic shock syndrome via suppression of tumor necrosis factor alpha production. Infect. Immun. 2005;73:3745-8.
29. Wendling D, Racadot E, Wijdenes J. Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody. J Rheumatol 1993;20:259-62.
30. Ito H, Takazoe M, Fukuda Y, Hibi T, Kusugami K, Andoh A et al. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology 2004;126:989-96.
31. Louis H, Van Laethem JL, Wu W, Quertinmont E, Degraef C, Van den Berg K et al. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology 1998;28:1607-15.
32. Arrieta MC, Madsen K, Doyle J, Meddings J. Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse. Gut 2009;58:41-8.
33. Roberts TL, Dunn JA, Terry TD, Jennings MP, Hume DA, Sweet MJ et al. Differences in macrophage activation by bacterial DNA and CpG-containing oligonucleotides. J Immunol 2005;175:3569-76.
34. Dowling D, Hamilton CM, O'Neill SM. A comparative analysis of cytokine responses, cell surface marker expression and MAPKs in DCs matured with LPS compared with a panel of TLR ligands. Cytokine 2008;41:254-62.
35. Daigneault M, Preston JA, Marriott HM, Whyte MK, Dockrell DH. The Identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS ONE 2010;5:e8668.
36. Tudhope SJ, Finney-Hayward TK, Nicholson AG, Mayer RJ, Barnette MS, Barnes PJ et al. Different mitogen-activated protein kinase-dependent cytokine responses in cells of the monocyte lineage. J Pharmacol Exp Ther 2008;324:306-12.